Our current data shows that tyrosine-phosphorylated STAT3 is highly expressed in advanced ovarian cancer and suggests that pSTAT3 Tyr705 may specifically be activated in those ovarian cancers that are hypoxic or have regions of hypoxia. Here, STAT3 is linked to ovarian cancer.